Sugi Predict

Sugi Predict / Compounds / 6-Benzylaminopurine

6-Benzylaminopurine

6-Benzylaminopurine

SCHEMBL725575

NC1(Cc2ccccc2)N=CN=C2N=CN=C21.c1ccc(CNc2ncnc3nc[nH]c23)cc1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 6/20 0.60
▸ TSHR P16473 5/20 0.60
▸ MAPK1 P28482 2/20 0.60
▸ CYP1A2 P05177 2/20 0.60
▸ CYP2D6 P10635 1/20 0.60
▸ CDK2 P24941 1/20 0.60
▸ HTT P42858 4/20 0.47
▸ TAAR1 Q96RJ0 1/20 0.47
▸ PRMT1 Q99873 1/20 0.47
▸ KDR P35968 2/20 0.47
▸ CSF1R P07333 2/20 0.47
▸ CDC7 O00311 1/20 0.47
▸ DBF4 Q9UBU7 1/20 0.47
▸ AURKA O14965 1/20 0.47
▸ DAPK3 O43293 1/20 0.47
▸ JAK2 O60674 1/20 0.47
▸ PRKD3 O94806 1/20 0.47
▸ MAP4K4 O95819 1/20 0.47
▸ PAK4 O96013 1/20 0.47
▸ ABL1 P00519 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Kinetin SCHEMBL7096263 0.90 SMN1; SMN2 (0.59) LMNATSHRMAPK1CYP1A2CYP2D6
Purine SCHEMBL28215545 0.78 CDC7 (0.32) LMNAHTTCDC7DBF4PRKACA
6-Benzylaminopurine SCHEMBL27965572 0.78 LMNA (1.00) LMNATSHRMAPK1CYP1A2CYP2D6
6-Benzylaminopurine SCHEMBL37358 0.78 LMNA (1.00) LMNATSHRMAPK1CYP1A2CYP2D6
6-Benzylaminopurine SCHEMBL29349525 0.78 LMNA (1.00) LMNATSHRMAPK1CYP1A2CYP2D6
6-Benzylaminopurine SCHEMBL30241517 0.76 LMNA (0.97) LMNATSHRMAPK1CYP1A2CYP2D6
6-Benzylaminopurine SCHEMBL8378682 0.76 LMNA (0.97) LMNATSHRMAPK1CYP1A2CYP2D6
6-Benzylaminopurine SCHEMBL11477809 0.76 LMNA (0.97) LMNATSHRMAPK1CYP1A2CYP2D6
6-Benzylaminopurine SCHEMBL218733 0.76 LMNA (0.97) LMNATSHRMAPK1CYP1A2CYP2D6
6-Benzylaminopurine SCHEMBL27886940 0.76 LMNA (0.97) LMNATSHRMAPK1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1671616-B1 Hair growth promoter composition LION CORP (JP) 2012-02-29 — — EP disclosed
US-20110108049-A1 METHOD FOR GROWING OR NOURISHING HEAD HAIR TOWA ENZYME CO., LTD. (JP) 2011-05-12 — — US disclosed
EP-2281551-A1 METHOD FOR GROWING OR NOURISHING HEAD HAIR TOWA Enzyme Co., Ltd. (JP) 2011-02-09 — — EP disclosed
US-7462604-B2 Hair growth promotor composition LION CORPORATION (JP) 2008-12-09 — — US disclosed
US-20070116657-A1 Hair growth promotor composition LION CORPORATION (JP) 2007-05-24 — — US disclosed
EP-1671616-A1 HAIR TONIC COMPOSITION Lion Corporation (JP) 2006-06-21 — — EP disclosed
CN-1336106-A Lycium Chinese hybrid breeding method NINGXIA INST OF FORESTRY CO LT (CN) 2002-02-20 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070116657-A1 Hair growth promotor composition BCOR, SPOUT1, IL36G LMNA 3795/4885TSHR 1903/4885MAPK1 1245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.